期刊文献+

磁共振弥散加权成像动态监测肿瘤血管靶向治疗的疗效 被引量:7

Diffusion-weighted imaging in dynamic monitoring the efficacy of tumor vascular targeting therapy
下载PDF
导出
摘要 目的探讨磁共振DWI监测肿瘤血管靶向治疗后动态变化的可行性。方法选取新西兰大白兔15只建立兔肌肉VX2肿瘤模型(共30个肿瘤)。分别于肿瘤血管靶向治疗(CA-4-P,20 mg/kg体质量)前及治疗后1、4、8、12天进行常规、增强MRI及DWI,比较相邻时间点肿瘤整体、肿瘤中心、周边及肌肉组织的ADC值动态变化,并与病理表现进行对照。结果肿瘤血管靶向治疗前(MR基线扫描),肿瘤整体、肿瘤中心、周边及肌肉组织的ADC值分别为(1.33±0.16)×10-3mm2/s、(1.30±0.23)×10-3mm2/s、(1.19±0.31)×10-3mm2/s及(1.66±0.13)×10-3mm2/s;镜下见肿瘤细胞生长旺盛。治疗后1天,肿瘤中心ADC值较MR基线扫描减低(P<0.05);镜下见肿瘤细胞肿胀,排列松散,靠近肿瘤中心处可见肿瘤细胞破裂、核固缩。治疗后4天,肿瘤整体、肿瘤中心及周边ADC值较治疗后1天增高(P均<0.05);镜下可见大范围肿瘤坏死。治疗后8天,肿瘤中心ADC值较治疗后4天增高(P<0.05);镜下见肿瘤中心坏死更加彻底。治疗后12天,肿瘤整体及肿瘤周边ADC值较治疗后8天减低(P均<0.05);镜下可见肿瘤周边新生的肿瘤组织。结论 DWI能准确反映兔肌肉VX2肿瘤模型CA-4-P给药后肿瘤组织的动态变化,可作为理想的肿瘤血管靶向治疗监测和疗效评价手段。 Objective To investigate the feasibility of DWI in monitoring the dynamic characteristics of tumors after vascular disrupting treatment.Methods Fifteen New Zealand white rabbits were selected,and the models of VX2 tumors in muscle(totally 30 lesions) were established.Conventional,enhanced MRI and DWI were performed before and 1,4,8,12 days after intravenous administration of combretastatin A4 phosphate(CA-4-P) with the dosage of 20 mg/kg.The dynamic changes of ADC value in entire,central,peripheral part of tumor and muscle between consecutive two time points were compared,respectively,while the changes of ADC and pathological manifestations were analyzed comparatively.Result Before vascular disrupting treatment(baseline MR scan),ADC in entire,central,peripheral part of tumor and muscle was(1.33±0.16)×10-3 mm2/s,(1.30±0.23)×10-3 mm2/s,(1.19±0.31)×10-3 mm2/s and(1.66±0.13)×10-3 mm2/s,respectively.Histology showed vigorous growth of VX2 carcinoma cells.One day after treatment,ADC value in central part of tumor was lower than that of baseline MR scan(P0.05).Tumor cell swelling and incompact arrangement were observed,while plasmatorrhexis and karyopyknosis were found in the area close to tumor centre with histological examination.Four days after treatment,ADC value in entire,central and peripheral part of tumor were higher than those at 1 day after treatment(all P0.05).Large range necrosis was observed.Eight days after treatment,ADC value in central part of tumor was higher than that at 4 days after treatment(P0.05),and the necrosis aggravated.Twelve days after treatment,ADC value in entire and peripheral part of tumor were lower than those at 8 days after treatment(all P0.05),while progressive tumor proliferation was found in peripheral part of tumor under optical microscope.Conclusion DWI can reveal the dynamic histological changes in rabbit VX2 tumors after intravenous administration of CA-4-P,therefore is an ideal method to monitor and evaluate the efficacy of vascular disrupting treatment.
出处 《中国医学影像技术》 CSCD 北大核心 2011年第3期457-461,共5页 Chinese Journal of Medical Imaging Technology
基金 沈阳市科学技术项目(F10-205-1-19) 辽宁省教育厅重点实验室项目(2009S110)
关键词 肿瘤 分子靶向治疗 考布他汀A4 扩散磁共振成像 Neoplasms Molecular targeted therapy Combretastatin A-4 Diffusion magnetic resonance imaging
  • 相关文献

参考文献7

  • 1Thoeny HC, De Keyzer F, Chen F, et al. Diffusion weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosareoma in rats. Radiology, 2005,234(3) :756-764.
  • 2Stevenson JP, Rosen M, Sun W, et al. Phase Ⅰ trial of the anti vascular agent combretastatin A4 phosphate on a 5-day scheduleto patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol, 2003,21 (23) : 4428-4438.
  • 3Anderson HL, Yap JT, Miller MP, et al. Assessment of phar maeodynamie vascular response in a phase Ⅰ trial of combretastatin A4 phosphate. J Clin Oneol, 2003,21(15):2823 2830.
  • 4Prise VE, Honess DJ, Stratford MR, et al. The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, eombretastatin A-4-phosphate, at clinically relevantdoses. Int J Oncol, 2002,21(4):717-726.
  • 5Bammer R. Basic principles of diffusion weighted imaging. Eur J Radiol, 2003,45(3):169-184.
  • 6肖运平,肖恩华,罗建光,卞读军,贺忠,尚全良,梁斌,李默秋.MR扩散成像在肝细胞癌经导管动脉化疗栓塞术后疗效评价中的价值[J].中国医学影像技术,2008,24(2):270-273. 被引量:34
  • 7张毅,郭顺林,雷军强,王文辉,白亮彩,赵茜静.磁共振扩散加权成像在肝癌介入治疗前后应用的初步研究[J].中国介入影像与治疗学,2006,3(3):182-185. 被引量:21

二级参考文献16

  • 1张毅,雷军强,王文辉,郭顺林.肝脏水分子扩散成像的临床应用进展[J].中国临床医学影像杂志,2005,16(7):404-406. 被引量:5
  • 2肖恩华,胡国栋,李锦清.无水乙醇碘油乳剂栓塞治疗肝细胞癌[J].中华放射学杂志,2005,39(10):1073-1076. 被引量:7
  • 3Colagrande S. Carbone SF, Carusi LM, et al. Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med (Torino), 2006, 111(3) :392-419.
  • 4Charles-Edwards EM, de Souza NM, Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging. 2006,6:135-143.
  • 5Yamada I, Aung W, Himeno Y, et al. Diffusion coefficients in ab dominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology, 1999, 210 (3) :617-623.
  • 6Guo AC. Cummings T J, Dash RC, et al. Lymphomas and highgrade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology, 2002,224( 1 ) : 177-183.
  • 7Chen CY. Li CW, Kuo YT, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants-initial experience. Radiology, 2006,239(2) :448-456.
  • 8Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusionweighted imaging in estimating tumor necrosis after chemoemholization of hepatocellular carcinoma. AJR, 2003, 181(3):708-710.
  • 9Ebara M, Fukuda H, Kojima Y, et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of tumor and surrounding hepatic parenchyma. Radiology, 1999,210(1) :81-88.
  • 10Valonen PK. Lehtimaki KK, Vaisanen TH, et al. Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density. J Magn Resoon Imaging, 2004,19(4) :389-396.

共引文献51

同被引文献57

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部